Draeger, Inc. Announces FDA Clearance for Evita V800 Software 3.10 - Advancing Ventilation Technology

Draeger, Inc., US headquarters of Dräger, an international leader in the field of medical technology and a worldwide leader ...
Tech Times

FDA Clears United Therapeutics LungFX: Lung Transplant Device for Discarded Donor Organs

Lung transplant device LungFX won FDA approval Monday for centralized ex vivo lung perfusion, a technology that reconditions ...
casereports.bmj

Tension pneumothorax in a patient with COVID-19

A 36-year-old man was brought to the emergency department with suspected COVID-19, following a 3-week history of cough, fevers and shortness of breath, worsening suddenly in the preceding 4 hours. On ...
Frontiers

Efficacy and Safety of Low-Dose Thrombolysis in Acute Intermediate-High Risk Pulmonary Thromboembolism Complicated by PaO2/FiO2 < 300

PaO2/FiO2 ratio and NT-proBNP were assessed at baseline, 24 hours, 3 days, and 7 days, while mPAP was measured at baseline, 24 hours, and 7 days. Safety endpoints included mortality, hemodynamic ...
Nature

Chronic Hypoxia and Rat Lung Development: Analysis by Morphometry and Directed Microarray

It is unclear how sublethal hypoxia affects lung development. To investigate the effects of chronic hypoxia on postnatal lung remodeling, we treated neonatal rats with FIO 2 of 0.12 for 10 d and ...
BMJ

Development and preclinical testing of an adaptive algorithm for automated control of inspired oxygen in the preterm infant

3 School of Engineering and ICT, University of Tasmania, Hobart, Tasmania, Australia 4 School of Medicine, University of Tasmania, Hobart, Tasmania, Australia Objective To assess the performance of a ...